Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Jan 15, 2019

SELL
$272.46 - $366.54 $39,234 - $52,781
-144 Closed
0 $0
Q3 2018

Oct 31, 2018

BUY
$279.04 - $367.06 $8,371 - $11,011
30 Added 26.32%
144 $53,000
Q1 2018

May 24, 2018

BUY
$209.54 - $253.91 $23,887 - $28,945
114 New
114 $27,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $21.4B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Trilogy Capital Inc. Portfolio

Follow Trilogy Capital Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trilogy Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Trilogy Capital Inc. with notifications on news.